Celon Pharma SA Sustainability Reports

Celon Pharma S.A. is an integrated biopharmaceutical company engaged in the research, development, manufacturing, and marketing of specialized generic and innovative medicinal products. The company focuses primarily on oncology, neuropsychiatry, autoimmunity, and metabolic diseases.

Sector: Manufacturing

Country: Poland

Exchange: Warsaw Stock Exchange

LEI: 259400Q0ERJT0NC5DT24

FIGI: BBG00DSJ1T68

7 reports from 2016 to 2025

• Celon Pharma SA 2025 Sustainability Report
• Celon Pharma SA 2021 Financial Statements Together with the Independent Statutory Auditor's Report
• Celon Pharma SA 2020 Historical Financial Data
• Celon Pharma SA 2019 Annual Report
• Celon Pharma SA 2018 Annual Report